Trial Profile
A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Apr 2018
Price :
$35
*
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Pulmonary tuberculosis
- Focus Therapeutic Use
- 18 Apr 2018 Status changed from recruiting to completed.
- 08 May 2017 Planned End Date changed from 1 Mar 2017 to 1 Dec 2017.
- 08 May 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Nov 2017.